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RESEARCH
Hospital admission and mortality rates for non-covid diseases 
in Denmark during covid-19 pandemic: nationwide population 
based cohort study
Jacob Bodilsen,1 Peter Brønnum Nielsen,2,3 Mette Søgaard,2,3 Michael Dalager-Pedersen,1 




To determine the incidence of hospital admissions 
and associated mortality rates for non-covid medical 
conditions during the covid-19 pandemic.
Design
Nationwide, population based cohort study.
setting
Denmark from 13 March 2019 to 27 January 2021.
ParticiPants
All Danish residents >1 year of age.
Main OutcOMes Measures
Population based healthcare registries that 
encompass the entire Danish population were used 
to compare hospital admission and mortality rates 
during the covid-19 pandemic (from 11 March 2020 
to 27 January 2021) with the prepandemic baseline 
data (from 13 March 2019 to 10 March 2020). 
Hospital admissions were categorised as covid-19 
when patients were assigned a diagnosis code for 
covid-19 within five days of admission. All patients 
were followed until migration, death, or end of follow-
up, whichever came first. Rate ratios for hospital 
admissions were computed using Poisson regression 
and were directly standardised using the Danish 
population on 1 January 2019 as reference. 30 day 
mortality rate ratios were examined by Cox regression, 
adjusted for age and sex, and covid-19 diagnosis was 
used as a competing risk.
results
5 753 179 residents were identified during 567.8 
million person weeks of observation, with 1 113 705 
hospital admissions among 675 447 people. 
Compared with the prepandemic baseline period 
(mean hospital admission rate 204.1 per 100 000/
week), the overall hospital admission rate for non-
covid-19 conditions decreased to 142.8 per 100 000/
week (rate ratio 0.70, 95% confidence interval 0.66 
to 0.74) after the first national lockdown, followed by 
a gradual return to baseline levels until the second 
national lockdown when it decreased to 158.3 per 
100 000/week (0.78, 0.73 to 0.82). This pattern was 
mirrored for most major diagnosis groups except for 
non-covid-19 respiratory diseases, nervous system 
diseases, cancer, heart failure, sepsis, and non-
covid-19 respiratory infections, which remained lower 
throughout the study period. Overall 30 day mortality 
rates were higher during the first national lockdown 
(mortality rate ratio 1.28, 95% confidence interval 
1.23 to 1.32) and the second national lockdown 
(1.20, 1.16 to 1.24), and these results were similar 
across most major diagnosis groups. For non-covid-19 
respiratory diseases, cancer, pneumonia, and sepsis, 
the 30 day mortality rate ratios were also higher 
between lockdown periods.
cOnclusiOns
Hospital admissions for all major non-covid-19 
disease groups decreased during national lockdowns 
compared with the prepandemic baseline period. 
Additionally, mortality rates were higher overall and 
for patients admitted to hospital with conditions such 
as respiratory diseases, cancer, pneumonia, and 
sepsis. Increased attention towards management of 
serious non-covid-19 medical conditions is warranted.
Introduction
The covid-19 pandemic has caused a global health 
crisis of historic proportions and has forced govern-
ments worldwide to impose dramatic restrictions 
within and between countries. These restrictions 
include hygienic precautions and measures of physical 
distancing such as quarantines, restrictions on public 
and private gatherings, and closure of schools, public 
workplaces, private businesses, and country borders.1
Government officials and hospital administrators 
have also prioritised healthcare services to decrease 
risks of system collapse. However, these prioritisations 
and public information campaigns of self-isolation 
could endanger patients with serious and acute 
non-covid-19 medical conditions.2 Previous studies 
examining hospital admission rates during the 
pandemic have mainly focused on a single non-
covid-19 acute medical condition, and most have 
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WhAt Is AlreAdy knoWn on thIs topIc
Early observations during the covid-19 pandemic suggest that patients might not 
have sought help for cardiovascular or neurological diseases
Some hospitals, overwhelmed by the pandemic, might not have been able to 
provide timely care for other serious and acute non-covid-19 medical conditions
WhAt thIs study Adds
Hospital admissions for all major non-infectious disease groups decreased 
during the two national lockdowns in Denmark
A gradual return to baseline levels was observed between lockdowns except 
for respiratory and nervous system diseases, cancer, heart failure, sepsis, and 
pneumonia
Higher 30 day mortality rates were observed for most major disease groups 
during national lockdowns, but also between lockdowns for hospital admissions 
due to respiratory diseases, cancer, pneumonia, and sepsis
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been restricted to one or a few hospitals within a 
certain healthcare programme or geographical region 
during a relative short period of time.3-13 Analyses 
of essential healthcare services at times of crisis are 
crucial for managing hospital responses and ensuring 
preparedness during the continued threat of covid-19 
and future epidemics. This study examined changes 
in hospital admission and mortality rates during the 
first 11 months of the covid-19 pandemic in Denmark 
using nationwide and population based healthcare 
registries.
Methods
setting and study population
This nationwide cohort study included data from 13 
March 2019 to 27 January 2021 and covered the entire 
Danish population (5 827 463 residents on 1 January 
2019; supplementary fig 1). In Denmark, the state 
provides all residents with free and unrestricted access 
to healthcare.14 A unique civil registration number is 
assigned to each resident at birth or immigration and 
is used for all healthcare contacts in Denmark. Data 
are recorded prospectively in nationwide registries, 
allowing longitudinal surveillance of the entire 
population at the individual level.
Data sources and study period
The Civil Registration System tracks migration, sex, age, 
and vital status of all Danish residents, with less than 
0.3% lost to follow-up.15 The Danish National Patient 
Registry covers all somatic hospitals in Denmark and 
has recorded discharge diagnoses of acute and elective 
hospital admissions since 1977, and outpatient clinic 
visits since 1995.16 Since 1994, diagnoses have been 
coded according to the World Health Organization’s 
international classification of diseases version 10 
(ICD-10). A major change in registration practices in 
the Danish National Patient Registry was implemented 
during January and February 2019 and therefore the 
study period started in March 2019 to ensure the 
internal validity of records for hospital admissions. 
Hospital admissions less than 12 hours apart were 
considered as one continued contact. Inpatient hospi-
tal admissions were defined as hospital contacts 
crossing midnight and of at least 12 hours’ duration. 
Data were excluded for infants (<1 year of age) and for 
people with recent migration status or inconsistent 
vital data (supplementary fig 2).
Pandemic stages and preventive measures
On 27 February 2020, the first Danish patient with 
covid-19 was identified after returning home from 
northern Italy. Within weeks, covid-19 became 
widely transmitted in the Danish community (fig 1). 
On 11 March 2020 the Danish government issued 
a comprehensive lockdown in Denmark, with the 
closure of schools and most workplaces, and the 
implementation of quarantines, border closings, and 
restriction on public gatherings.17 Some hospitals 
suspended non-urgent elective surgery and outpatient 
visits in preparation for an expected high number of 
covid-19 admissions; on 17 March, this suspension 
was extended to all Danish hospitals. The number of 
new patients with covid-19 quickly decreased after 
the national lockdown, and from 15 April onwards 
restrictions were gradually rolled back. During summer 
2020, covid-19 incidence remained low and hospitals 
reduced the backlog of patients requiring non-urgent 
care. However, by the autumn, several regional 
outbreaks had occurred, which led to a second and 
more severe wave of covid-19 on a national level in 
late 2020. Therefore, in Denmark six phases of the 
covid-19 pandemic can be defined:
1. Pre-covid-19 baseline from 13 March 2019 to 10 
March 2020
2. First national lockdown phase from 11 March to 
15 April 2020
3. Gradual reopening phase from 16 April to 8 June 
2020
4. Few restrictions from 9 June to 30 September 
2020
5. Regional lockdown phase from 1 October to 15 
December 2020
6. Second national lockdown from 16 December 
2020 to 27 January 2021.
Outcomes
From 13 March 2019 to 27 January 2021, all non-
covid-19 hospital admissions were identified by 
principal diagnosis codes in the Danish National 
Patient Registry. These codes were grouped according 
to major ICD-10 diagnosis group (supplementary table 
1) identified by the first primary code given within the 
listed chapters. However, if a patient was assigned a 
diagnosis code for covid-19 within five days of hospital 
admission, the admission was categorised as covid-19. 
We used the Civil Registration System to compute 
30 day mortality rates for non-covid-19 hospital 
admissions, overall and according to selected major 
disease groups. Because covid-19 could have been 
associated with changes in essential medical services 
in Denmark, all analyses were repeated for selected 
acute medical conditions diagnosed within 24 hours 
of hospital admission: myocardial infarction, heart 
failure, stroke, intracranial bleeding, exacerbation 
of chronic pulmonary disease, pneumonia, sepsis, 
urinary tract infection, and bone, skin and soft tissue 
infections.
statistical analyses
We examined overall hospital admission rates 
stratified by major disease groups. For these analyses, 
direct standardisation was performed by using the age 
(10 year intervals) and sex distribution of the Danish 
population on 1 January 2019 as reference. We used a 
Poisson regression model, with log of the population 
size as offset, to estimate standardised weekly hospital 
admission rates. The rates were adjusted for number 
of working days per week and public holidays because 
elective hospital contacts are mainly scheduled during 
regular weekdays. We computed hospital admission 
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rate ratios and 95% confidence intervals by using the 
pre-covid-19 baseline period as reference. A sandwich 
estimator for robust estimation of covariances was 
used to account for potential overdispersion. We 
then repeated the analyses for biweekly periods and 
stratified patients as having prevalent disease, when 
the patient had previously been assigned a hospital 
diagnosis code for the major disease group or medical 
condition, or incident disease, when a hospital 
diagnosis code was first assigned for the major disease 
group or medical condition.
We assessed mortality risk at 30 days after non-
covid-19 hospital admission by using the Kaplan-Meier 
estimator, with censoring at emigration, diagnosis 
of covid-19, or end of follow-up (28 February 2021), 
whichever occurred first. Mortality risk ratios and 
robust 95% confidence intervals were calculated using 
Cox proportional regression models adjusted for age 
and sex, and using a diagnosis of covid-19 within 30 
days after the index date as competing risk. Because 
we excluded people with inconsistent vital status, 
there were no missing data for hospital admissions or 
death.
We used Stata MP version 16 (Statacorp, College 
Station, TX) for all statistical analyses, and a P value 
of 0.05 was applied for testing statistical significance.
Patient and public involvement
Patients were not included in the design or conduct 
of this study. Barriers for including patient and public 
involvement were time sensitivity in carrying out the 
study (covid pandemic) and lack of funding.
results
The study comprised 5 753 179 Danish residents 
identified during 567.8 million person weeks of 
observation, yielding a total of 1 113 705 hospital 
admissions distributed among 675 447 people (table 
1). Of those admitted to hospital, 68.5% were admitted 
once, 17.5% were admitted twice, and 14% had three 
or more admissions during the study period.
The overall mean hospital admission rate in 
Denmark was 204.1 per 100 000/week during the 
baseline period (table 2), and approximately 210 when 
not considering periods of decreased activity such as 
Christmas, Easter, and summer holidays (fig 1). When 
we used the baseline period as reference, the mean 
hospital admission rate for non-covid-19 conditions 
decreased to 142.8 (rate ratio 0.70, 95% confidence 
interval 0.66 to 0.74) after the first national lockdown, 
178.6 (0.88, 0.84 to 0.92) during the gradual 
reopening phase, 188.8 (0.92, 0.90 to 0.96) during the 
period with few restrictions, 193.9 (0.95, 0.92 to 0.98) 
during the regional lockdown phase, and 158.3 (0.78, 
0.73 to 0.82) during the second national lockdown.
Hospital admission rates for major disease groups
Compared with hospital admissions for infectious 
disease during the prepandemic baseline period, 
the hospital admission rate ratio for non-covid-19 
infectious diseases was 0.73 (95% confidence interval 
0.70 to 0.76) during the first national lockdown (table 
2). Lower hospital admission rates followed, with 
rate ratios of 0.85 (0.81 to 0.89) during the gradual 
reopening phase, 0.93 (0.90 to 0.97) during the 
period with few restrictions, 0.90 (0.88 to 0.92) during 
regional lockdowns, and 0.77 (0.75 to 0.80) during the 
second national lockdown.
For all other major diagnosis groups, hospital 
admission rate ratios decreased markedly during the 
first and second national lockdowns compared with 
the rates during the baseline period, ranging from 
0.34 (0.25 to 0.46) for bone, muscle, and connective 
tissue diseases to 0.86 (0.80 to 0.91) for cancer 
during the first national lockdown. These lower rates 
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Mar 19 Oct 19 Mar 20 Jun 20 Oct 20 Dec 20 Feb 21
Overall hospital admission rate per 100 000/week
Daily hospital admissions for covid-19
30 day mortality rate per 1000 hospital admissions
Gradual reopening (16 Apr-8 Jun)
Few restrictions (9 Jun-30 Sep)
Regional lockdowns (1 Oct-15 Dec)
Second national lockdown (16 Dec-)
Fig 1 | standardised overall hospital admission rates, absolute number of daily admissions for covid-19, and 30 day 
mortality rates in Denmark during covid-19 pandemic
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among patients with previously diagnosed conditions 
(prevalent disease) in most specialties, including those 
with extensive outpatient appointments or elective 
admissions (fig 2). However, substantially lower 
rates were also observed among first time hospital 
admissions (incident disease) for conditions such as 
respiratory, circulatory, neurological, haematological, 
digestive, and psychiatric diseases during the first 
national lockdown.
Compared with the prepandemic baseline period, 
hospital admission rates remained consistently lower 
for several major disease groups during the phases 
of gradual reopening, few restrictions, and regional 
lockdowns, including respiratory diseases, cancer, 
and nervous system diseases. For respiratory diseases, 
the rate ratios were 0.63 (0.60 to 0.66) during gradual 
reopening, 0.73 (0.70 to 0.77) during few restrictions, 
and 0.70 (0.66 to 0.73) during regional lockdowns. 
Although generally less severe in magnitude, the 
lower hospital admission rates observed during the 
second national lockdown for all major disease groups 
mirrored those of the first national lockdown.
Hospital admission rates for selected acute medical 
conditions
Compared with the baseline period, hospital ad-
missions were significantly lower for all non-covid-19 
infections during the first and second national 
lockdowns. The hospital admission rate ratios were 
0.64 (95% confidence interval 0.58 to 0.69) for bone, 
skin, and soft tissue infections, 0.65 (0.61 to 0.69) 
for acute exacerbation of chronic pulmonary disease, 
0.71 (0.60 to 0.83) for pneumonia, 0.76 (0.68 to 0.85) 
for urinary tract infections, and 0.77 (0.73 to 0.82) 
for sepsis during the first national lockdown. The 
observed lower rates were comparable among patients 
with prevalent and incident disease (fig 3). Hospital 
admission rates for all non-covid-19 infections 
remained lower throughout the study period except 
for urinary tract infections and bone, skin, and soft 
tissue infections, which returned to baseline levels by 
the gradual reopening and few restrictions periods, 
respectively.
Substantially fewer hospital admissions for some 
non-infectious acute medical conditions were also 
observed during the first national lockdown compared 
with the prepandemic baseline period, with rate ratios 
of 0.74 (0.65 to 0.83) for heart failure, 0.89 (0.79 to 
0.99) for intracranial bleeding, 0.89 (0.86 to 0.93) 
for stroke, and 0.90 (0.80 to 1.01) for myocardial 
infarction. The observations were predominated by 
fewer first time hospital admissions for myocardial 
infarction and stroke, whereas the lower rates for heart 
failure were attributable to a combination of fewer 
hospital admissions among patients with prevalent 
and incident disease. Hospital admission rates 
remained lower for heart failure throughout the study 
period and returned to baseline levels for myocardial 
infarction, stroke, and intracranial bleeding later 
during the study period, including the second national 
lockdown.
Mortality
Major disease groups—the overall 30 day mortality 
rate ratios among people admitted to hospital 
increased during the first national lockdown (1.28, 
95% confidence interval 1.23 to 1.32) and the second 
national lockdown (1.20, 1.16 to 1.24) compared with 
the prepandemic baseline period (table 3). The same 
pattern was observed for a range of major disease 
groups and acute medical conditions, such as non-
covid-19 infections, bone, muscle, and connective 
tissue, genitourinary, respiratory, digestive, and 
circulatory diseases, and injuries or poisoning. 
However, the 30 day mortality rate ratios also remained 
higher for infectious diseases overall (with and without 
covid-19), cancer, and respiratory diseases in time 
periods between the two national lockdowns.
Acute medical conditions—compared with the 
prepandemic baseline period, the 30 day mortality 
rate ratio was 1.40 (95% confidence interval 1.27 to 
1.55) for pneumonia, 1.39 (1.23 to 1.57) for sepsis, 
table 1 | baseline characteristics of Danish population (>1 year of age), overall and among those admitted to hospital within different time periods 












No of people 5 753 179 416 034 46 362 64 433 151 824 98 410 58 706
Age (years), mean (SD) 41.8 (23.4)* 59.9 (22.4) 61.0 (22.0) 60.5 (22.2) 60.2 (22.4) 60.6 (22.1) 61.8 (21.9)
 0-20 21.4 (1 231 783)* 5.7 (35 152) 4.6 (2375) 5.2 (3852) 5.4 (10 281) 5.3 (6091) 4.4 (2931)
 21-40 25.4 (1 463 171)* 15.8 (97 329) 15.9 (8290) 15.6 (11 472) 16.2 (30 851) 15.4 (17 805) 15.3 (10 183)
 41-60 27.0 (1 553 768)* 18.8 (115 783) 17.9 (9300) 18.4 (13 476) 18.2 (34 704) 18.4 (21 296) 17.5 (11 683)
 61-80 21.4 (1 230 024)* 40.3 (248 065) 41.0 (21 325) 40.5 (29 732) 40.2 (76 564) 40.9 (47 390) 40.4 (26 950)
 ≥81 4.8 (274 433)* 19.3 (118 877) 20.7 (10 755) 20.3 (14 885) 20.0 (38 077) 20.1 (23 269) 22.4 (14 962)
Female population 50.3 (2 892 854)* 53.6 (329 970) 52.6 (27 361) 53.3 (39 141) 53.8 (102 384) 53.6 (62 086) 53.0 (35 327)
No of hospital admissions 1 113 705 615 206 52 045 73 417 19 477 115 851 66 709
Million person weeks  
of observation 567.8 299.2 29.6 44.4 94.0 62.7 38.0
SD=standard deviation.
Overall population from 13 March 2019 to 27 January 2021; baseline period from 13 March 2019 to 10 March 2020, 364 days; first national lockdown from 11 March 2020 to 15 April 2020, 
36 days; gradual reopening from 16 April 2020 to 8 June 2020, 54 days; few restrictions from 9 June 2020 to 30 September 2020, 114 days; regional lockdowns from 1 October 2020 to 15 
December 2020, 76 days; second national lockdown from 16 December 2020 to 27 January 2021, 46 days.
*Population characteristics in Denmark on 11 March 2020.
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and 1.23 (1.01 to 1.50) for urinary tract infections 
during the first national lockdown. For patients with 
a diagnosis of sepsis, the 30 day mortality rates were 
also higher during regional lockdowns, whereas rates 




We used nationwide, population based healthcare 
registries encompassing the entire Danish population 
and observed 30% and 22% lower overall hospital 


































































































































































































































































































































































































Fig 2 | non-covid-19 hospital admission rates by icD-10 (international classification of diseases version 10) chapters in Denmark from March 2019 to 
january 2021. Data are stratified according to whether hospital admission concerns patients with prevalent or incident disease
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in the first 11 months of the covid-19 pandemic 
in Denmark. Although a gradual return close to 
baseline levels occurred for most major disease 
groups between lockdowns, hospital admission rates 
remained lower throughout the study period for 
some medical conditions; for example, respiratory 
and nervous system diseases, cancer, heart failure, 
acute exacerbations of chronic pulmonary disease, 
sepsis, and pneumonia. Concomitantly, higher 30 
day mortality rates were observed overall and across 
a range of major disease groups during both national 
lockdowns and also between these time periods for 
respiratory diseases, cancer, pneumonia, and sepsis.
comparison with other studies
Since the onset of the covid-19 pandemic, physicians 
and researchers around the world have been worried 
about the potential collateral effect on almost all 
aspects of healthcare.2 18-22 These concerns involve 
patients not seeking care when needed and reduced 
capacity of overburdened healthcare services to 
provide timely diagnoses and treatment.3-13 A recent 
report from four hospitals in New York, an epicentre 
of covid-19 at the early stages in the United States, 
reported decreases of more than 50% in overall hos-
pital contacts across several major disease groups.5 
These findings might partly reflect an overwhelmed 
healthcare system as suggested by another study that 
observed fewer hospital admissions at a tertiary care 
centre in New York compared with a similar facility 
in California, which was less severely affected by 
covid-19 at that time.4 In contrast, the overall decrease 
in hospital admission rates in the current study was a 
predictable consequence of the restrictions imposed by 
the Danish government at an early stage of the pandemic 


































































































































































































































Fig 3 | Hospital admission rates by selected acute medical conditions in Denmark from March 2019 to january 2021. Data are stratified according to 
whether hospital admission concerns patients with prevalent or incident disease
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essential healthcare. Although hospital admission 
rates gradually approached baseline levels for most 
major disease groups before the second national 
lockdown, important and substantially lower rates 
persisted for some serious medical conditions such 
as respiratory diseases and cancer. These lower rates 
were observed for new patients not being diagnosed 
and for patients with known disease not treated at 
hospital or monitored by specialised outpatient follow-
up. Reports on the productivity of general practitioners 
by the Danish Board of Health observed that physical 
consultations also dropped markedly during the early 
stages of the covid-19 pandemic and were only partially 
replaced by telephone consultations, video calls, and 
table 3 | thirty day mortality (%) among patients admitted to hospital for non-covid-19 medical conditions during covid-19 pandemic in Denmark 





First national lockdown gradual reopening Few restrictions regional lockdowns
second national  
lockdown
risk
risk ratio  
(95% ci) risk
risk ratio  
(95% ci) risk
risk ratio  
(95% ci) risk
risk ratio  
(95% ci) risk
risk ratio  
(95% ci)
Overall 5.3 6.9 1.28  (1.23 to 1.32) 5.6
1.02  
(0.99 to 1.06) 5.3
0.99  
(0.96 to 1.01) 5.6
1.04  
(1.01 to 1.07) 6.6
1.20  
(1.16 to 1.24)
Including covid-19  
admissions 5.3 7.4
1.36  
(1.31 to 1.41) 5.7
1.04  
(1.01 to 1.08) 5.3
0.99 
(0.97 to 1.01) 5.8
1.07  




Infectious diseases 9.8 13.5 1.39  (1.23 to 1.56) 9.7
0.94  
(0.83 to 1.06) 9.3
0.92  
(0.85 to 1.00) 11.9
1.15  
(1.05 to 1.26) 13.7
1.32  
(1.18 to 1.48)
Including covid-19  
admissions 9.7 15.7
1.75  
(1.60 to 1.91) 11.0
1.08  
(0.97 to 1.20) 9.4
0.93  
(0.86 to 1.01) 12.4
1.25  
(1.15 to 1.35) 16.9
1.72  
(1.60 to 1.85)
Cancer 9.6 10.5 1.09  (0.99 to 1.20) 10.5
1.10  
(1.00 to 1.20) 10.2
1.06  
(0.99 to 1.13) 10.7
1.12  
(1.04 to 1.20) 10.9
1.14  
(1.04 to 1.25)
Haematological disorders 5.2 6.3 1.15  (0.89 to 1.49) 5.2
0.95  
(0.76 to 1.20) 4.9
0.91  
(0.78 to 1.07) 5.4
1.05  
(0.87 to 1.26) 6.5
1.19  
(0.95 to 1.49)
Endocrine, nutrition, and 
metabolism 7.9 10.2
1.17  
(1.00 to 1.37) 8.4
1.02  
(0.89 to 1.17) 8.0
0.94  
(0.86 to 1.03) 8.0
1.05  
(0.93 to 1.17) 8.8
1.07  
(0.92 to 1.23)
Mental and behavioural 
disorders 4.0 4.0
0.95  
(0.62 to 1.45) 4.6
1.08  
(0.78 to 1.48) 3.8
0.95  
(0.76 to 1.18) 5.0
1.19  
(0.92 to 1.53) 5.8
1.42  
(1.04 to 1.95)
Diseases of the nervous 
system 2.1 3.0
1.31  
(0.91 to 1.88) 2.4
1.07  
(0.78 to 1.47) 2.6
1.23  
(1.00 to 1.52) 2.0
0.98  
(0.74 to 1.29) 2.6
1.18  
(0.85 to 1.65)
Sensory organ disease 1.0 0.6 0.58  (0.14 to 2.40) 1.1
1.05  
(0.45 to 2.44) 0.9
0.83  
(0.45 to 1.53) 1.4
1.35  
(0.74 to 2.48) 1.5
1.40  
(0.64 to 3.06)
Circulatory disease 5.6 6.9 1.22  (1.11 to 1.35) 5.7
1.00  
(0.92 to 1.10) 5.6
1.00  
(0.94 to 1.06) 6.0
1.06  
(0.99 to 1.14) 6.8
1.18  
(1.08 to 1.29)
Respiratory diseases 11.6 14.7 1.26  (1.17 to 1.36) 13.5
1.16  
(1.07 to 1.25) 13.0
1.12  
(1.07 to 1.18) 13.5
1.17  
(1.10 to 1.24) 15.4
1.28  
(1.18 to 1.38)
Digestive diseases 4.3 5.6 1.25  (1.10 to 1.43) 4.0
0.90  
(0.79 to 1.02) 4.3
0.98  
(0.90 to 1.06) 4.4
1.01  
(0.92 to 1.12) 5.5
1.23  
(1.09 to 1.38)
Dermatological diseases 2.2 4.1 1.88 (1.13 to 3.12) 2.3
1.05  
(0.61 to 1.81) 2.0
0.93  
(0.63 to 1.36) 1.9
0.83  
(0.51 to 1.36) 2.2
0.96  
(0.52 to 1.77)
Bone, muscle, and  
connective tissues 0.9 2.3
2.32  
(1.66 to 3.23) 1.2
1.25  
(0.94 to 1.66) 1.1
1.11  
(0.92 to 1.35) 1.0
1.05  
(0.83 to 1.32) 1.8
1.84  
(1.39 to 2.44)
Genitourinary system 4.7 6.1 1.25  (1.07 to 1.46) 5.6
1.15  
(1.00 to 1.31) 4.7
0.93  
(0.85 to 1.03) 5.2
1.05  
(0.93 to 1.17) 6.2
1.22  
(1.06 to 1.40)
Injury or poisoning 4.0 5.2 1.25  (1.10 to 1.43) 4.6
1.12  
(0.99 to 1.26) 4.1
1.01  
(0.93 to 1.10) 4.7
1.12  
(1.01 to 1.24) 5.3
1.21  
(1.08 to 1.36)
selected acute medical conditions
Myocardial infarction 4.7 4.8 1.01  (0.72 to 1.41) 4.4
0.90  
(0.66 to 1.23) 4.7
0.97  
(0.78 to 1.21) 4.4
0.92  
(0.70 to 1.20) 5.5
1.11  
(0.84 to 1.48)
Heart failure 10.2 11.1 1.10  (0.88 to 1.39) 8.7
0.83  
(0.67 to 1.03) 10.0
0.99  
(0.86 to 1.15) 11.1
1.06  
(0.90 to 1.26) 11.5
1.11  
(0.91 to 1.36)
Stroke 6.4 7.2 1.12  (0.88 to 1.42) 6.0
0.92  
(0.73 to 1.15) 5.4
0.84  
(0.72 to 0.99) 6.8
1.04  
(0.87 to 1.25) 7.9
1.20  
(0.97 to 1.47)
Intracranial bleeding 22.1 24.3 1.12  (0.86 to 1.46) 23.2
1.05  
(0.82 to 1.35) 25.0
1.19  
(1.01 to 1.40) 25.3
1.15  
(0.95 to 1.40) 26.3
1.21  
(0.96 to 1.53)
Acute exacerbation of 
chronic pulmonary disease 8.1 9.2
1.14  
(0.96 to 1.36) 8.1
0.98  
(0.82 to 1.17) 8.4
1.04  
(0.93 to 1.16) 9.4
1.15  
(1.00 to 1.32) 11.3
1.33  
(1.13 to 1.56)
Pneumonia 13.3 18.4 1.40 (1.27 to 1.55) 17.1
1.30  
(1.17 to 1.44) 16.2
1.20  
(1.12 to 1.28) 17.2
1.30  
(1.19 to 1.41) 19.0
1.38  
(1.25 to 1.53)
Sepsis 15.0 19.8 1.39 (1.23 to 1.57) 14.0
0.91  
(0.81 to 1.03) 15.3
1.00  
(0.92 to 1.08) 17.5
1.15  
(1.04 to 1.26) 18.3
1.20  
(1.07 to 1.35)
Urinary tract infection 6.5 8.0 1.23 (1.01 to 1.50) 7.0
1.06  
(0.89 to 1.26) 6.5
0.97  
(0.86 to 1.09) 7.5
1.09  
(0.94 to 1.25) 7.1
1.04  
(0.87 to 1.25)
Bone, skin, and soft  
tissue infections 3.4 3.6
1.09  
(0.69 to 1.72) 3.8
1.03  
(0.72 to 1.49) 2.4
0.67  
(0.50 to 0.89) 4.2
1.16  
(0.86 to 1.56) 4.8
1.32  
(0.93 to 1.88)
ICD-10=international classification of diseases version 10.
Mortality rate ratio adjusted for age and sex. Patients admitted to hospital with non-covid-19 medical conditions and subsequently with a diagnosis of covid-19 within 30 days of the index date 
were censored at day of covid-19 diagnosis.
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e-mail.23 24 This decrease was especially pronounced 
for children aged 0-4 years, adults aged >70 years, 
and immigrants. By late April 2020, consultations had 
returned to baseline levels, suggesting no major shift 
in management of serious diseases from hospital to 
primary care.
A few previous reports also observed lower hospital 
admission rates for myocardial infarctions,6 10-12 
heart failure,5 9 and stroke3 8 13 during the initial peak 
of covid-19 that were comparable to or even more 
pronounced than estimates of the current study. In 
general, fewer hospital admissions could represent 
genuinely lower incidences of diseases because of 
lifestyle and behavioural changes during lockdown. 
However, concerns remain about reluctance of patients 
to seek care because of perceived risks of contracting 
covid-19 at hospital, negligence to report symptoms, 
and decreased hospital capacity to manage these 
patients. In our study, the moderately lower hospital 
admission rates for acute myocardial infarction 
and stroke during lockdown were mainly driven by 
fewer patients with a first time diagnosis, whereas 
the persistently lower rates observed in patients 
with heart failure might partly represent deferred 
outpatient follow-up. Physical distancing and hygienic 
precautions probably contributed to fewer admissions 
for respiratory tract infections and sepsis, whereas 
reasons for the observed decreases in urinary tract 
infections or bone, skin, and soft tissue infections are 
less obvious.
clinical implications
A potential and concerning consequence of patients 
not seeking appropriate care for medical emergencies 
could be an increase in mortality and morbidity. In 
contrast to some other countries, we did not observe 
an overall excess mortality on a population level 
in Denmark until the second national lockdown in 
December 2020 (fig 1).25-29 A key component of this 
observation is probably the greater severity of the 
second wave of covid-19 in Denmark and associated 
deaths, which might have outweighed the decreased 
overall absolute number of hospital admissions and 
deaths due to other conditions at that time. The find- 
ings of higher relative mortality rates for patients 
admitted with other infections that could mimic 
covid-19, such as pneumonia, sepsis, and urinary 
tract infections, were also of great concern. These 
higher rates could be due to delayed presentation 
and progression to more severe disease in some 
patients. Additionally, the implementation of isolation 
precautions in a burdened healthcare system (primary 
and hospital care) could further hinder appropriate 
examinations and time dependent treatments.
These results should be interpreted with caution 
and additional studies are needed to clarify whether 
our observations represent a significantly higher 
mortality rate adjusted for disease severity, or whether 
they merely reflect increased self or primary care 
management of less severe conditions. Because cancer is 
an adverse prognostic factor of covid-19,30 31 the higher 
mortality rate in these patients could be attributable to 
undiagnosed covid-19. Other reasons might include 
the accumulation of more insidious adverse collateral 
effects of the pandemic on timely diagnosis and long 
term management of patients with cancer.
limitations and generalisability
Important limitations include lack of access to data 
on primary care management for estimates on disease 
frequencies, and clinical details on disease severity 
and comorbidities of people admitted to hospital 
in analyses of mortality. Danish healthcare and 
administrative registries have been shown to be of 
high quality,14 16 32 but differential misclassification 
of conditions with a similar clinical presentation as 
covid-19 cannot be excluded and could introduce bias 
in an unpredictable direction. Although our results 
might not be directly comparable to some healthcare 
systems, the generalisability is strengthened by the 
nationwide and population based setting within a tax 
financed healthcare system accounting for all hospital 
admissions and the vital status of each Danish resident 
on the individual level.
conclusions
Hospital admission rates were substantially lower for 
all major non-infectious disease groups during the two 
national lockdowns. Although hospital admissions 
had gradually returned to baseline levels for many 
conditions in the time periods between lockdowns, 
important exceptions were respiratory and nervous 
system diseases, cancer, pneumonia, sepsis, and heart 
failure. At the same time, higher 30 day mortality rates 
were observed for most major disease groups during 
national lockdowns, but also in the time periods 
between the lockdowns for hospital admissions due to 
respiratory diseases, cancer, pneumonia, and sepsis.
Contributors: JB, TY, LOZS, FS, PBN, MS, MDP, HN, and TBL conceived 
and designed the study. FS performed the data management and 
conducted all statistical analyses. JB wrote the first draft and is the 
guarantor for the study. The corresponding author attests that all 
listed authors meet authorship criteria and that no others meeting the 
criteria have been omitted.
Funding: None.
Competing interests: All authors have completed the ICMJE uniform 
disclosure form at www.icmje.org/coi_disclosure.pdf and declare: no 
support from any organisation for the submitted work; no financial 
relationships with any organisations that might have an interest in the 
submitted work in the previous three years; no other relationships or 
activities that could appear to have influenced the submitted work.
Ethical approval: The study was approved by the legal 
representatives of North Denmark Region (2020-046). In Denmark, 
patient consent or approval from an ethics committee is not necessary 
for this type of study. The data were provided by the Danish Health 
Data Authority.
Data sharing: For legal reasons, individual level raw data from Danish 
administrative and health registries cannot be shared by the authors.
The lead author (JB) affirms that this manuscript is an honest, 
accurate, and transparent account of the study being reported; that 
no important aspects of the study have been omitted; and that any 
discrepancies from the study as planned (and, if relevant, registered) 
have been explained.
Dissemination to participants and related patient and public 
communities: Besides publication in the British Medical Journal, the 
main results of the study will be announced in a press release by the 
North Denmark Region.
 on 26 M










J: first published as 10.1136/bm






No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
Provenance and peer review: Not commissioned; externally peer 
reviewed.
This is an Open Access article distributed in accordance with the 
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, 
which permits others to distribute, remix, adapt, build upon this work 
non-commercially, and license their derivative works on different 
terms, provided the original work is properly cited and the use is non-
commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
1  World Health Organization. WHO releases guidelines to help 




2  Rosenbaum L. The untold toll – the pandemic’s effects on 
patients without Covid-19. New Engl J Med . 2020. doi:10.1056/
nejmms2009984
3  Baum A, Schwartz MD. Admissions to Veterans Affairs hospitals 
for emergency conditions during the COVID-19 pandemic. 
JAMA 2020;324:96-9. doi:10.1001/jama.2020.9972
4  Bhambhvani HP, Rodrigues AJ, Yu JS, Carr JB2nd, Hayden Gephart 
M. Hospital volumes of 5 medical emergencies in the COVID-19 
pandemic in 2 US medical centers. JAMA Intern Med 2021;181:272-
4. doi:10.1001/jamainternmed.2020.3982
5  Blecker S, Jones SA, Petrilli CM, et al. Hospitalizations for chronic 
disease and acute conditions in the time of COVID-19. JAMA Intern 
Med 2021;181:269-71. doi:10.1001/jamainternmed.2020.3978
6  De Rosa S, Spaccarotella C, Basso C, et al, Società Italiana di 
Cardiologia and the CCU Academy investigators group. Reduction of 
hospitalizations for myocardial infarction in Italy in the COVID-19 era. 
Eur Heart J 2020;41:2083-8. doi:10.1093/eurheartj/ehaa409
7  Baldi E, Sechi GM, Mare C, et al. Out-of-hospital cardiac arrest during 
the covid-19 outbreak in Italy. New Engl J Med . 2020. doi:10.1056/
nejmc2010418
8  Rinkel LA, Prick JCM, Slot RER, et al. Impact of the COVID-19 outbreak 
on acute stroke care. J Neurol . 2020. doi:10.1007/s00415-020-
10069-1
9  Sokolski M, Gajewski P, Zymlinski R, et al. Impact of coronavirus 
disease 2019 (COVID-19) outbreak on acute admissions at the 
emergency and cardiology departments across Europe. Am J Med . 
2020. doi:10.1016/j.amjmed.2020.08.043
10  Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment 
elevation cardiac catheterization laboratory activations in the 
United States during COVID-19 pandemic. J Am Coll Cardiol . 2020. 
doi:10.1016/j.jacc.2020.04.011
11  Solomon MD, McNulty EJ, Rana JS, et al. The covid-19 pandemic and 
the incidence of acute myocardial infarction. New Engl J Med . 2020. 
doi:10.1056/nejmc2015630
12  Filippo OD, D’Ascenzo F, Angelini F, et al. Reduced rate of hospital 
admissions for ACS during covid-19 outbreak in northern Italy. New 
Engl J Med . 2020. doi:10.1056/nejmc2009166
13  Kansagra AP, Goyal MS, Hamilton S, Albers GW. Collateral effect 
of Covid-19 on stroke evaluation in the United States. N Engl J 
Med 2020;383:400-1. doi:10.1056/NEJMc2014816
14  Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care 
system and epidemiological research: from health care contacts to 
database records. Clin Epidemiol 2019;11:563-91. doi:10.2147/
CLEP.S179083
15  Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration 
System as a tool in epidemiology. Eur J Epidemiol 2014;29:541-9. 
doi:10.1007/s10654-014-9930-3
16  Schmidt M, Schmidt SAJ, Sandegaard JL, Ehrenstein V, Pedersen 
L, Sørensen HT. The Danish National Patient Registry: a 
review of content, data quality, and research potential. Clin 
Epidemiol 2015;7:449-90. doi:10.2147/CLEP.S91125
17  Danish Board of Health. Covid-19 status and management in 
Denmark. 2021. https://www.sst.dk/da/corona/Status-for-
epidemien/Statusrapporter.
18  Nelson B. Covid-19 is shattering US cancer care. 
BMJ 2020;369:m1544. doi:10.1136/bmj.m1544
19  Dore B. Covid-19: collateral damage of lockdown in India. 
BMJ 2020;369:m1711. doi:10.1136/bmj.m1711
20  Mayor S. COVID-19: impact on cancer workforce and delivery of care. 
Lancet Oncol 2020;21:633. doi:10.1016/S1470-2045(20)30240-
0
21  DeJong C, Katz MH, Covinsky K. Deferral of care for serious non-
COVID-19 conditions: a hidden harm of COVID-19. JAMA Intern 
Med 2021;181:274. doi:10.1001/jamainternmed.2020.4016
22  Anil I, Arnold R, Benkwitz-Beford S, et al. The UK Coronavirus 
Cancer Monitoring Project: protecting patients with cancer in 
the era of COVID-19. Lancet Oncol . 2020. doi:10.1016/S1470-
2045(20)30230-8
23  The Danish Board of Health (Danish). COVID-19: Monitorering af 
aktivitet i sundhedsvæsenet. Beskrivelse af udviklingen i aktivitet i 




24  The Danish Board of Health (Danish). General practice in Denmark 
- monitoring and analyses. 2021. https://sundhedsdatastyrelsen.
dk/da/tal-og-analyser/analyser-og-rapporter/sundhedsvaesenet/
almenpraksis.
25  Kontis V, Bennett JE, Rashid T, et al. Magnitude, demographics 
and dynamics of the effect of the first wave of the COVID-19 
pandemic on all-cause mortality in 21 industrialized countries. Nat 
Med 2020;26:1919-28. doi:10.1038/s41591-020-1112-0
26  Lai AG, Pasea L, Banerjee A, et al. Estimated impact of the COVID-19 
pandemic on cancer services and excess 1-year mortality in people 
with cancer and multimorbidity: near real-time data on cancer 
care, cancer deaths and a population-based cohort study. BMJ 
Open 2020;10:e043828. doi:10.1136/bmjopen-2020-043828
27  Bilinski A, Emanuel EJ. COVID-19 and excess all-cause mortality 
in the US and 18 comparison countries. JAMA 2020;324:2100-2. 
doi:10.1001/jama.2020.20717
28  Vestergaard LS, Nielsen J, Richter L, et al, ECDC Public Health 
Emergency Team for COVID-19. Excess all-cause mortality 
during the COVID-19 pandemic in Europe - preliminary pooled 
estimates from the EuroMOMO network, March to April 2020. 
Euro Surveill 2020;25:2001214. doi:10.2807/1560-7917.
ES.2020.25.26.2001214
29  Weinberger DM, Chen J, Cohen T, et al. Estimation of excess deaths 
associated with the COVID-19 pandemic in the United States, March 
to May 2020. JAMA Intern Med 2020;180:1336-44. doi:10.1001/
jamainternmed.2020.3391
30  Lee LYW, Cazier JB, Starkey T, et al. COVID-19 mortality in patients 
with cancer on chemotherapy or other anticancer treatments: a 
prospective cohort study. The Lancet . 2020. doi:10.1016/S0140-
6736(20)31173-9
31  Reilev M, Kristensen KB, Pottegård A, et al. Characteristics and 
predictors of hospitalization and death in the first 11 122 cases 
with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide 
cohort. Int J Epidemiol 2020;49:1468-81. doi:10.1093/ije/dyaa140
32  Frank L. Epidemiology. When an entire country is a cohort. 
Science 2000;287:2398-9. doi:10.1126/science.287.5462.2398 
Web appendix: Supplementary material
 on 26 M










J: first published as 10.1136/bm
j.n1135 on 24 M
ay 2021. D
ow
nloaded from
 
